Fulgent Genetics, Inc. (FLGT) has a negative trailing P/E of -7.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -12.77%.
Criteria proven by this page:
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -38.2 | 0.72 | 3.75 | 11.19 | 2.25% |
| 2017 | -31.0 | 0.62 | 1.44 | 4.15 | - |
| 2018 | -10.2 | -0.15 | 1.09 | 2.67 | - |
| 2019 | -587.2 | 6.38 | 2.92 | 7.42 | - |
| 2020 | 5.5 | 0.00 | 2.08 | 2.80 | - |
| 2021 | 5.8 | 0.07 | 2.55 | 2.98 | - |
| 2022 | 6.3 | -0.09 | 0.71 | 1.45 | - |
| 2023 | -5.1 | 0.02 | 0.76 | 2.98 | - |
| 2024 | -13.1 | 0.17 | 0.49 | 1.97 | - |
| 2025 | -13.4 | -0.34 | 0.73 | 2.51 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.30 | $18.28M | $-5.35M | -29.3% |
| 2017 | $-0.15 | $18.73M | $-2.51M | -13.4% |
| 2018 | $-0.25 | $21.36M | $-5.61M | -26.3% |
| 2019 | $-0.02 | $32.53M | $-411K | -1.3% |
| 2020 | $8.91 | $421.71M | $214.31M | 50.8% |
| 2021 | $16.26 | $992.58M | $507.36M | 51.1% |
| 2022 | $4.63 | $618.97M | $143.4M | 23.2% |
| 2023 | $-5.63 | $289.21M | $-167.83M | -58% |
| 2024 | $-1.41 | $283.47M | $-42.71M | -15.1% |
| 2025 | $-1.97 | $322.67M | $-60.51M | -18.8% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.41 | $-1.51 – $-1.30 | $348.28M | $346.57M – $349.98M | 2 |
| 2027 | $-1.48 | $-1.71 – $-1.26 | $390.7M | $389.07M – $392.32M | 2 |
| 2028 | $-1.44 | $-1.46 – $-1.42 | $434.09M | $434.09M – $434.09M | 1 |
